Stay updated on Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedShow glossary option added and metadata labels updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page now includes a centralized 'Locations' section listing US sites by state (California, Florida, Georgia, Indiana, Michigan, Ohio, Tennessee, Texas, Virginia) and removes the separate 'X Locations' sections; it also shows the revision tag Revision: v3.3.3.SummaryDifference0.9%

- Check68 days agoChange DetectedThe page shows a new revision label, updating from v3.2.0 to v3.3.2, which appears to be a minor documentation or UI update. There are no evident changes to study content, eligibility, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page no longer displays the notice about a lapse in government funding and NIH operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check90 days agoChange DetectedThe update on the page is limited to Study Record Dates metadata (e.g., Last Update Posted now shown as 2025-02-04 and related QC dates); no changes were made to the core study design, eligibility criteria, outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.